Navigation Links
Mental Disorders Drugs Market - New Industry Research Report Is Now Available for Pre-Order at Transparency Market Research

Albany, New York (PRWEB) August 23, 2013

A mental disorder is a psychological anomaly that is reflected in the behavior of the patient through distress, disability or any conduct that is not a part of a person’s normal mental development. The causes of mental disorders are varied in nature and many are also unclear. Psychiatric medication and psychotherapy are the two modes of treatment for mental disorder. In psychiatric medication drug classes such as antidepressants, anxiolytics, and antipsychotics are most commonly used.

Browse the report with Request TOC at

Improvement in patient security policy, growth in domestic and foreign investment in the field of mental medication, and increase in the prevalence and the related awareness about mental health are the major drivers for the global mental disorders drugs market. However, skepticism about social pressure regarding mental diseases and their treatment, especially in less advanced countries, and the lack of government initiatives in such locations may hold back the growth of this market.

The overall mental disorders drugs market can be classified on the basis of the mental drugs such as antidepressants, antipsychotics, anxiolytics, drugs for schizophrenia, drugs for childhood and adolescent mental illness, and drugs for the treatment of substance and alcohol addiction, bipolar disease drugs, and others.

North America is the largest market for mental disorders drugs. Factors such as increasing government initiatives, better reimbursement policies, and general awareness about mental health and treatment are responsible for the growth of this market in this region. An increase in the awareness about the efficacy of mental disorders’ drugs and growth in the related clinical evidence will assist in the rapid growth of this market in Asia-Pacific. The major players in the mental disorders drugs market include pharmaceutical manufacturers such as Eli Lilly, AstraZeneca, Pfizer, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
North America
Asia Pacific
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse all Market Research reports:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Mental Illness Tied to Higher Rates of Physical Problems: Report
3. Researchers ID Genes That May Determine Mental Illness
4. First contact: Early intervention key in diagnosis and treatment of serious mental illness
5. Media Multitasking Might Have Mental Upside
6. Experimental Pill for Multiple Sclerosis Shows Promise
7. Experimental Gel May Help Those With Advanced Parkinsons
8. Talking to Yourself Could Have Mental Benefits
9. Experimental Drug Eases Autistic Behaviors in Mice
10. Understanding and promoting mental health - Insights from psychological science
11. Developmental Woes Common in Siblings of Children With Autism
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology: